Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

ANNUAL GENERAL MEETING IN CONCENTRIC AB

The Concentric AB board of directors has resolved to convene an annual general meeting of shareholders to be held Thursday 21 April 2022. Further details on the proposals can be found in the notice convening the meeting, below. The notice is expected to be published in the Swedish Official Gazette (Post- och Inrikes Tidningar) and on the company’s website within the next few days.Annual general meeting in Concentric AB The annual general meeting of Concentric AB will be held at 12.00 CET on Thursday 21 April 2022 at Klara strand, S:ta Clara, Klarabergsviadukten 90, in Stockholm.

Sibanye-Stillwater Closes EUR 5 Million of Equity Investment in Keliber

On 14 March 2022, in line with the investment agreement, the final tranche of Sibanye Stillwater Ltd’s (SSW) investment in Keliber was closed with SSW subscribing 125,000 shares for EUR 5 million. This increases SSW’s shareholding to approximately 30%. It is SSW’s final tranche of the EUR 30 million phased equity investment the companies announced on 23 February 2021. SSW subscribed shares for a total of EUR 15 million in March 2021 and for an additional EUR 10 million in September 2021. For more information, please contact Riku Sauso, Chief Financial Officer, Keliber, mobile

Sharp increase of interest in Enviro’s recovered materials as a result of the war in Ukraine

Since the Russian invasion of Ukraine on February 24, Enviro has noted a sharp increase of interest in purchasing the carbon black and oil that Enviro recovers from end-of-life tyres. The increased interest has been observed among old and new customers, but the company cannot yet assess what this will mean in terms of specific orders or supply agreements. “The increase in interest entails that we will need to set priorities carefully, while it also confirms that we were wise not to be in a hurry to sign long-term supply agreements connected to our expansion plan,” says Thomas Sörensson,

Norway Royal Salmon (NRS): Engagement of Financial Advisor and notice to Extraordinary General Meeting.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA, SOUTH AFRICA, NEW ZEALAND, JAPAN OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFULTrondheim, 17 March 2022. Norway Royal Salmon ASA (“NRS” or the “Company”) hereby announces that it has engaged ABG Sundal Collier as Sole Financial Advisor in relation to the financing process related to the acquisition of SalmoNor AS (“SalmoNor”). Over the next few weeks,

EOS Russia - Year-End Report 1 January - 31 December 2021

· The loss for EOS during the period was SEK -58.6 million (-155.3). Loss per share was SEK -1.73 (-4.37). Total comprehensive income for the period was SEK 6.9 million (-248.0). · EOS recorded a net loss from investing activities of SEK -51.6 million (-143.5) comprising net dividends of SEK 21.1 million (46.9) and a negative development in the investment portfolio of SEK -72.7 million (-190.4). · Operating expenses amounted to SEK -11.3 million (-11.4).  · Net financial items for the period amounted to SEK 4.3 million (-0.4).  · EOS’ net asset value at December 31, 2021 was

Betting.bet Launches New Online Betting App

Global online betting aggregator, betting.bet, has announced that it has launched its first mobile application.The online betting app , which is free to download on both iOS and Android devices, allows bettors to enjoy the much-loved betting.bet service on the go. With many features to boast, this app helps players to navigate the latest deals from betting and casino sites across the world, all of which have been vetted and verified. "Our in-house team have spent months developing this application, the features of

Nordisk Bergteknik completes its largest acquisition to date - expands in the Stockholm region through acquisitions of Rovalin and Soil Mixing Group

Nordisk Bergteknik has today entered into an agreement regarding the acquisition of all shares in Infrastructure Group Nordic AB (“IGN”), a subsidiary of Connecting Capital, with the operating subsidiaries Rovalin and Soil Mixing Group. IGN, which has a turnover of approximately SEK 420 million with good profitability, offers services primarily in foundation and soil reinforcement. Through the acquisition, Nordisk Bergteknik expands in the Stockholm region, one of the Nordic region's largest local markets in foundations, at the same time as the Group's offering is complemented and

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 70 - 17 MARCH 2022 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp participates by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in Dampskibsselskabet NORDEN A/S. The market will be informed accordingly – see the attached file and announcement no. 56/2022. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information:Thomas France, Investor Communications Partner, tel.: 3315 0451

STENOCARE A/S publishes Annual Report 2021

STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER: STENO The Board of Directors and the Chief Executive Officer of STENOCARE A/S (“STENOCARE”) hereby publishes the annual report of the fiscal year 2021. The annual report including the auditor’s report is available as an attached file and on the websites of STENOCARE and Nasdaq First North .Thomas Skovlund Schnegelsberg, CEO of STENOCARE, comments: “Looking back at 2021, it was a year of hard work, with

Dutch university medical center orders Sectra’s digital pathology solution for full-scale primary diagnostics

Linköping, Sweden – March 17, 2022 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) has signed a digital pathology contract with Erasmus University Medical Center (Erasmus MC) in the Netherlands. The solution will enable pathologists to review and collaborate around cases in a way that is not possible with microscopes. This will reduce variation and increase efficiency in primary diagnostics, thereby improving cancer care.“With Sectra’s digital pathology solution, we are able to integrate it with our vendor-neutral archive (VNA). That

Atlas Copco to acquire US-based manufacturer of process equipment for the semiconductor industry

Nacka, Sweden, March 17, 2022: Atlas Copco has agreed to acquire the assets of Ceres Technologies, Inc., a US-based manufacturer and designer of gas and vapour delivery equipment for the semiconductor industry.The acquisition includes assets of two affiliates, North Park Metalworkers, Inc. and Peak Precision Technologies, Inc. In 2021 they had revenues of approximately MUSD 41 (MSEK 351). The acquired companies have around 185 employees. Ceres Technologies, Inc. was founded in 2011 and is located in the Hudson Valley, New York area. As well as providing gas and vapour delivery equipment

New order regarding SAAB NLAW

KebNi AB (publ) has received a supplementary order regarding the IMU for Saab´s NLAW missileStockholm, 17 March 2022 – Today, Kebni announces a supplementary 110 KSEK order from Saab that relates to the ongoing development project. As earlier communicated, Saab has contracted Kebni to develop and provide a tailored IMU (Inertial Sensing Unit) for their product NLAW. The IMU is a key component for the missile’s navigation.The project proceeds well and in accordance with Saab’s time plan. Development work is currently ongoing, which is planned to be followed by industrialization and

Ratos makes changes to leadership of Oase Outdoors

Oase Outdoors (Oase) co-founder Henrik Arens will pass on his current role as CEO to Henrik Bernth in late summer 2022. In conjunction with the appointment of a new CEO, Henrik Arens will take on the role as Chairman of the Board of Oase. Anders Slettengren, President Business Area Consumer at Ratos and current Chairman of the Board, will continue as a Board member.Henrik Arens has, for many years, provided the leadership and experience required to bring Oase to its current position as a leading manufacturer of camping equipment in the European market. Henrik Bernth is well known to many in

Notice to EAB Group Plc’s Annual General Meeting

EAB Group Plc, Stock Exchange Release, 17 March 2022, 9:30 a.m. (EET) Notice to EAB Group Plc’s Annual General Meeting EAB Group Plc’s shareholders are invited to the Annual General Meeting to be held on Thursday 7 April 2022 as from 12.00 EET. The meeting is held through exceptional arrangements without the presence of the shareholders at the Company’s premises at Kluuvikatu 3, 3rd floor, Helsinki. The Board of Directors of the Company has resolved upon an exceptional General Meeting procedure pursuant to a temporary act (Act No 375/2021 on temporary derogation from the Limited

Trevian and Bayer favour sustainable choices in office premises selection

Selecting sustainability enhancing office spaces is an efficient way for companies to implement environmental responsibility and promote energy efficiency to fight against climate change. Trevian Asset Management has a purposeful goal to obtain an environmental rating in accordance with European standards for all office buildings it manages. This also supports the environmental objectives and sustainable development of the property users. Bayer considers premises solutions as a significant component in achieving its ambitious sustainability targets.Environmental responsibility is measured

Realheart recruits clinical strategist and electronics expert

Press release 17 March 2022 Realheart has brought on board Australian consultant Sara Diab, who will support the company's regulatory and clinical strategy, and electronics expert Nicolas Barabino, based in Spain, who will support the development of the clinical control unit for the Realheart TAH.Sara Diab is a former IVA nurse who now works as a medical device specialist with over 10 years of experience in the development of artificial hearts – everything from ethics applications and trial planning to data collection and reporting. ''Sara Diab has an incredibly important skill set

BERGENBIO ANNOUNCES PUBLICATION IN CELL REPORTS MEDICINE JOURNAL INDICATING EFFICACY OF BEMCENTINIB IN STK11/LKB1 LUNG CANCER POPULATION

The article identifies the key role of AXL inhibition in restoring response to immune checkpoint blockade therapy in lung cancer with mutations in the STK11/LKB1 gene   Bergen, Norway – 17 March 2022 – BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL inhibitors for severe unmet medical needs, today announces the publication of a peer-reviewed article entitled “AXL targeting restores PD-1 blockade sensitivity of STK11/LKB1 mutant NSCLC through expansion of TCF1+ CD8+ T cells” in the journal Cell Reports Medicine.   The article

NoHo Partners Plc's Financial Statements, Corporate Governance Statement and Remuneration Report 2021 published

NoHo Partners PlcSTOCK EXCHANGE RELEASE 17 March 2022 at 9:15 a.m.NoHo Partners Plc's Financial Statements, Corporate Governance Statement and Remuneration Report 2021 published NoHo Partners Plc's Financial Statements and Report of the Board of Directors, auditor’s report, Corporate Governance Statement and Remuneration Report for the financial period that ended on 31 December 2021 have been published today on 17 March 2022. NoHo Partners Plc published its financial statements for the first time as an XHTML file compliant with the reporting requirements of the European Single

Enfo Group’s financial statement bulletin January 1 – December 31, 2021

Enfo 2021: Stable performance reinforced with new strategyQ4/2021 · Net sales in October-December were EUR 27.5 (26.8) million · EBITDA was EUR 2.1 (2.7) million · EBIT was EUR 0.0 (0.3) million · Profit for the period was EUR -0.5 (0.1) million · Earnings per share were EUR -0.6 (-1.5) · Operating cash flow was EUR 2.2 (1.9) million   Full-year 2021 · Net sales in 2021 were EUR 103.9 (101.5) million · EBITDA was EUR 7.4 (7.7) million · EBIT was EUR -2.3 (-1.5) million · Profit for the period was EUR -3.9 (-2.7) million · Earnings per share were

Share Options to Incentivise Long Term Performance

17 March 2022 IOG plc Grant of Share Options to Incentivise Long-Term Performance IOG plc ("IOG", or "the Company"), (AIM: IOG.L), the Net Zero UK gas and infrastructure operator focused on high return projects, announces that, under its Company Share Option Plan, it has today granted options over, in aggregate, 4,700,614 1p Ordinary Shares in the Company ("Ordinary Shares") to its executive directors, senior management and all employees to incentivise long-term performance (the "LTIP Options"). Following staff departures, the total net new LTIP issuance is 268,917 options as 4,431,

HusCompagniet generates more than DKK 4.3 billion in revenue for 2021 and deliver strong margins in a challenging market

Company announcement 12/2022 HusCompagniet sets new sales record with an increase of 24% of houses sold in 2021, which has been driven by an extraordinary high demand in H1 2021. Deliveries also increased with 12% to 1,831 houses. The increases have both been the highest in Group history. Reported revenue was DKK 4,315 million for 2021 corresponding to 20% growth from the revenue of 2020. EBITDA before special items increased by 16% to DKK 401 million corresponding to a margin of 9.3%. The overall performance of HusCompagniet has been satisfactory despite challenging markets.   "I’m

Settlement of patent litigation for Ultomiris

17 March 2022 07:00 GMT AstraZeneca reaches settlement agreement resolving patent litigation related to Ultomiris Alexion, AstraZeneca's Rare Disease group, has entered into a settlement agreement with Chugai Pharmaceutical Co., Ltd. (Chugai), resolving all patent disputes between the two companies related to Ultomiris (ravulizumab). In accordance with the settlement agreement, Alexion and Chugai have taken steps to withdraw patent infringement proceedings filed with US District Court for the District of Delaware and Tokyo District Court.  Marc Dunoyer, Chief Executive Officer,

Konftel Announces Global Award Winners

Collaboration endpoint specialist Konftel has announced a series of global award winners, in tribute to some of its top performing distribution partners.Each year Konftel highlights its key distributors around the world with a special accolade, spanning best partners and largest growth, across different territories. The company says 2021 saw a continuing expansion and strengthening of relationships, as part of a dedicated ‘channel only’ route to market.  Director of Global Sales, Tommy Edlund, believes Konftel is ideally placed to help resellers and their customers in the continuing

BERGENBIO TO PRESENT AT CARNEGIE VIRTUAL NORDIC HEALTHCARE SEMINAR

Bergen, Norway, 17 March 2022 – BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, is pleased to announce that CEO Martin Olin will be presenting at the Carnegie Virtual Nordic Healthcare Seminar taking place today at 15:15 CET. The presentation will be made available on the Company’s website in the Investors section shortly after the presentation. -Ends- Contacts  Martin OlinChief Executive Officer, BerGenBio ASAir@bergenbio.com   Rune SkeieChief Financial Officer,

There are no items matching the current filter
There are no more items matching the current filter
Back to top